Blocking β-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells

被引:59
作者
Gu, Wei [1 ,2 ]
Pan, Feng [3 ]
Singer, Robert H. [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
[3] NYU, Med Ctr, Skirball Inst, Mol Neurobiol Program, New York, NY 10012 USA
关键词
ZBP1; repression; Promoter methylation; Wnt-beta-catenin signaling; Cell proliferation; Metastasis; ACTIN MESSENGER-RNA; PRIMARY MAMMARY-TUMORS; PROTEIN CRD-BP; C-MYC; DNA METHYLATION; STABILIZING PROTEIN; CONFERS RESISTANCE; IN-VITRO; GROWTH; LOCALIZATION;
D O I
10.1242/jcs.045278
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ZBP1 (zipcode-binding protein 1, also known as IMP-1) is an mRNA regulator, functioning in mRNA localization, stability and translational control. ZBP1 is actively expressed during embryogenesis and tumorigenesis, but its expression is repressed in metastatic breast-cancer cell lines and tumors. In this article, we show that downregulation of ZBP1 expression results from its promoter methylation, an epigenetic process that remodels the chromatin structure and frequently represses gene activity. Demethylation of the ZBP1 promoter in metastatic cells reactivated ZBP1 expression, owing to restoration of the interaction of the ZBP1 promoter with beta-catenin. Loss of ZBP1 function not only increased growth ability of metastatic cells, but also promoted cell migration. We identified a number of mRNAs that were selectively associated with ZBP1 in breast-cancer cells. Many of these are involved in cell motility and in cell-cycle regulation, and displayed altered expression patterns in the absence of ZBP1. These data suggest that repression of ZBP1 deregulates its associated mRNAs, leading to the phenotypic changes of breast cancers.
引用
收藏
页码:1895 / 1905
页数:11
相关论文
共 57 条
[1]   Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death [J].
Abe, T ;
Toyota, M ;
Suzuki, H ;
Murai, M ;
Akino, K ;
Ueno, M ;
Nojima, M ;
Yawata, A ;
Miyakawa, H ;
Suga, T ;
Ito, H ;
Endo, T ;
Tokino, T ;
Hinoda, Y ;
Imai, K .
JOURNAL OF GASTROENTEROLOGY, 2005, 40 (05) :504-510
[2]  
Bender CM, 1998, CANCER RES, V58, P95
[3]   CONTROL OF C-MYC MESSENGER-RNA HALF-LIFE INVITRO BY A PROTEIN CAPABLE OF BINDING TO A CODING REGION STABILITY DETERMINANT [J].
BERNSTEIN, PL ;
HERRICK, DJ ;
PROKIPCAK, RD ;
ROSS, J .
GENES & DEVELOPMENT, 1992, 6 (04) :642-654
[4]   Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line [J].
Biliran, H ;
Wang, Y ;
Banerjee, X ;
Xu, HM ;
Heng, H ;
Thakur, A ;
Bollig, A ;
Sarkar, FH ;
Liao, JD .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :6075-6086
[5]   Gene expression profiling in single cells within tissue [J].
Capodieci, P ;
Donovan, M ;
Buchinsky, H ;
Jeffers, Y ;
Cordon-Cardo, C ;
Gerald, W ;
Edelson, J ;
Shenoy, SM ;
Singer, RH .
NATURE METHODS, 2005, 2 (09) :663-665
[6]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[7]  
Condeelis J, 2005, BIOL CELL, V97, P97
[8]   Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms [J].
Coniglio, Salvatore J. ;
Zavarella, Salvatore ;
Symons, Marc H. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (12) :4162-4172
[9]   USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY FOR CELL-GROWTH ASSAYS IN CULTURE [J].
CORY, AH ;
OWEN, TC ;
BARLTROP, JA ;
CORY, JG .
CANCER COMMUNICATIONS, 1991, 3 (07) :207-212
[10]   The rise and fall of genomic methylation in cancer [J].
El-Osta, A .
LEUKEMIA, 2004, 18 (02) :233-237